Get started
Author

Paola Rossi

Observed name: Rossi, Paola
ORCID: 0009-0002-7749-9711
Observed ORCID: 0009-0002-7749-9711
OpenAlex ID: A5101975673
Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study
2022 · Marco Massari, Stefania Spila Alegiani, et al. · PLoS Medicine · 59
Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project
2021 · Gianluca Trifirò, Valentina Isgrò, et al. · BioDrugs · 42
Comparing clinical trial population representativeness to real-world users of 17 biologics approved for immune-mediated inflammatory diseases: An external validity analysis of 66,639 biologic users from the Italian VALORE project
2024 · Ylenia Ingrasciotta, Andrea Spini, et al. · Pharmacological Research · 29
Switching patterns of biological drugs in patients with psoriasis and psoriatic arthritis: insight from the VALORE database network
2024 · Andrea Spini, Giorgia Pellegrini, et al. · Expert Opinion on Biological Therapy · 19
Gestational diabetes mellitus: Impact of adherence on patient management and maternal-neonatal complications
2023 · Federico Pigato, Riccardo Candido, et al. · Primary care diabetes · 13
PDF
Single and multiple switches, swap and retransitioning among 28,073 biological drug users with inflammatory bowel diseases: results from the Italian VALORE network
2025 · Giorgia Pellegrini, Andrea Spini, et al. · Therapeutic Advances in Gastroenterology · 6
Improving Drug Safety in Pediatric and Young Adult Patients with Hemato-Oncological Diseases: A Prospective Study of Active Pharmacovigilance
2024 · Anna Parzianello, Giulia Fornasier, et al. · Pharmaceuticals · 6
PDF
SMS-Based Active Surveillance of Adverse Events following Immunization in Children: The VigiVax Study
2024 · Laura Augusta Gonella, Francesca Moretti, et al. · Vaccines · 5
PDF
Frequency of Biological Drug Use in Older Patients with Immune-Mediated Inflammatory Diseases: Results from the Large-Scale Italian VALORE Distributed Database Network
2025 · Federica Soardo, Andrea Spini, et al. · BioDrugs · 4
PDF
Trajectories of biologic drug use before, during and after pregnancy: an Italian cohort study from the VALORE project
2024 · Sara Lopes, Michela Servadio, et al. · Expert Opinion on Biological Therapy · 4
PDF
Trajectories of Adherence to Biologics in Patients With Inflammatory Bowel Diseases: A Large‐Scale Multi‐Regional Italian Study Through the VALORE Distributed Database
2025 · Sabrina Giometto, Andrea Spini, et al. · Pharmacoepidemiology and Drug Safety · 3
PDF
Trend in the use of biological drugs in pediatric patients with immune-mediated inflammatory diseases: Insight from the large-scale Italian VALORE project
2025 · Chiara Bellitto, Ylenia Ingrasciotta, et al. · Pharmacological Research · 2
Safety of influenza vaccine during the vaccination campaign 2021/2022 in Italy: a self-controlled case series study
2026 · Stefania Spila-Alegiani, Marco Massari, et al. · Vaccine · 1
Comparative risk of serious infections across biological drugs in patients with psoriatic arthritis or psoriasis: A target trial emulation using the Italian VALORE distributed database network
2026 · Andrea Spini, Luca L’Abbate, et al. · Pharmacological Research · 1
Impact of Regional Healthcare Policy Interventions on Biosimilar Use: A 10-year Evaluation of TNFα Inhibitors Utilization in Italy
2026 · Giacomo Vitturi, Luca Piccoli, et al. · Pharmaceutical Medicine
PDF
Ten-year trend of rituximab use for hematological malignancies: a multiregional real-world study using the Italian VALORE distributed database network
2025 · Federica Soardo, Andrea Spini, et al. · Expert Opinion on Biological Therapy
Works count: 20
Citation count: 236
H-index: 6
I10-index: 6
Year
Topic
Type